Global Gene Therapy Competitive Landscape Professional Research Report 2025
Research Summary
Gene therapy is a therapeutic approach that involves the introduction, modification, or replacement of genetic material within an individual＇s cells to treat or prevent diseases. This innovative field aims to address the underlying genetic causes of various disorders, including genetic diseases, certain types of cancer, and other conditions with a genetic component. Gene therapy can be achieved by delivering therapeutic genes using viral vectors or non-viral methods to target cells, correcting genetic mutations, enhancing or suppressing gene expression, or introducing entirely new genetic material. In the context of genetic diseases, gene therapy seeks to provide functional copies of missing or defective genes, restoring normal cellular function. The field has shown particular promise in treating certain genetic disorders, such as cystic fibrosis and some types of inherited blindness. Ongoing research and clinical trials continue to expand the applications of gene therapy, offering potential breakthroughs in the treatment of a wide range of diseases.
According to DIResearch's in-depth investigation and research, the global Gene Therapy market size was valued at XX Million USD in 2024 and is projected to reach XX Million USD by 2032, with a CAGR of XX% (2025-2032). Notably, the China market has changed rapidly in the past few years. By 2024, China's market size is expected to be XX Million USD, representing approximately XX% of the global market share. By 2032, it is anticipated to grow further to XX Million USD, contributing XX% to the worldwide market share.
The major global manufacturers of Gene Therapy include Biogen, Novartis, Gilead Sciences, Sarepta Therapeutics, Alnylam Pharmaceuticals, Amgen, Spark Therapeutics, Akcea Therapeutics, bluebird bio, Sunway Biotech, AnGes, SIBIONO, Orchard Therapeutics, Human Stem Cells Institute etc. The global players competition landscape in this report is divided into three tiers. The first tier comprises global leading enterprises that command a substantial market share, hold a dominant industry position, possess strong competitiveness and influence, and generate significant revenue. The second tier includes companies with a notable market presence and reputation; these firms actively follow industry leaders in product, service, or technological innovation and maintain a moderate revenue scale. The third tier consists of smaller companies with limited market share and lower brand recognition, primarily focused on local markets and generating comparatively lower revenue.
This report studies the market size, price trends and future development prospects of Gene Therapy. Focus on analysing the market share, product portfolio, prices, sales, revenue and gross profit margin of global major manufacturers, as well as the market status and trends of different product types and applications in the global Gene Therapy market. The report data covers historical data from 2020 to 2024, based year in 2025 and forecast data from 2026 to 2032.
The regions and countries in the report include North America, Europe, China, APAC (excl. China), Latin America and Middle East and Africa, covering the Gene Therapy market conditions and future development trends of key regions and countries, combined with industry-related policies and the latest technological developments, analyze the development characteristics of Gene Therapy industries in various regions and countries, help companies understand the development characteristics of each region, help companies formulate business strategies, and achieve the ultimate goal of the company's global development strategy.
The data sources of this report mainly include the National Bureau of Statistics, customs databases, industry associations, corporate financial reports, third-party databases, etc. Among them, macroeconomic data mainly comes from the National Bureau of Statistics, International Economic Research Organization; industry statistical data mainly come from industry associations; company data mainly comes from interviews, public information collection, third-party reliable databases, and price data mainly comes from various markets monitoring database.
Global Key Manufacturers of Gene Therapy Include:
Biogen
Novartis
Gilead Sciences
Sarepta Therapeutics
Alnylam Pharmaceuticals
Amgen
Spark Therapeutics
Akcea Therapeutics
bluebird bio
Sunway Biotech
AnGes
SIBIONO
Orchard Therapeutics
Human Stem Cells Institute
Gene Therapy Product Segment Include:
Viral Gene Therapy
Non-Viral Gene Therapy
Gene Therapy Product Application Include:
Neurological Diseases
Cancer
Other
Chapter Scope
Chapter 1: Product Research Range, Product Types and Applications, Market Overview, Market Situation and Trends
Chapter 2: Global Gene Therapy Industry PESTEL Analysis
Chapter 3: Global Gene Therapy Industry Porter’s Five Forces Analysis
Chapter 4: Global Gene Therapy Major Regional Market Size and Forecast Analysis
Chapter 5: Global Gene Therapy Market Size and Forecast by Type and Application Analysis
Chapter 6: North America Passenger Gene Therapy Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 7: Europe Gene Therapy Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 8: China Gene Therapy Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 9: APAC (Excl. China) Gene Therapy Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 10: Latin America Gene Therapy Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 11: Middle East and Africa Gene Therapy Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 12: Global Gene Therapy Competitive Analysis of Key Manufacturers (Revenue, Market Share, Regional Distribution and Industry Concentration)
Chapter 13: Key Company Profiles (Product Portfolio, Revenue and Gross Margin)
Chapter 14: Industrial Chain Analysis, Include Raw Material Suppliers, Distributors and Customers
Chapter 15: Research Findings and Conclusion
Chapter 16: Methodology and Data Sources
- 1 Gene Therapy Market Overview
- 1.1 Product Definition and Statistical Scope
- 1.2 Gene Therapy Product by Type
- 1.2.1 Viral Gene Therapy
- 1.2.2 Non-Viral Gene Therapy
- 1.3 Gene Therapy Product by Application
- 1.3.1 Neurological Diseases
- 1.3.2 Cancer
- 1.3.3 Other
- 1.4 Global Gene Therapy Market Size Analysis (2020-2032)
- 1.5 Gene Therapy Market Development Status and Trends
- 1.5.1 Gene Therapy Industry Development Status Analysis
- 1.5.2 Gene Therapy Industry Development Trends Analysis
- 2 Gene Therapy Market PESTEL Analysis
- 2.1 Political Factors Analysis
- 2.2 Economic Factors Analysis
- 2.3 Social Factors Analysis
- 2.4 Technological Factors Analysis
- 2.5 Environmental Factors Analysis
- 2.6 Legal Factors Analysis
- 3 Gene Therapy Market Porter's Five Forces Analysis
- 3.1 Competitive Rivalry
- 3.2 Threat of New Entrants
- 3.3 Bargaining Power of Suppliers
- 3.4 Bargaining Power of Buyers
- 3.5 Threat of Substitutes
- 4 Global Gene Therapy Market Analysis by Regions
- 4.1 Gene Therapy Overall Market: 2024 VS 2025 VS 2032
- 4.2 Global Gene Therapy Revenue and Forecast Analysis (2020-2032)
- 4.2.1 Global Gene Therapy Revenue and Market Share by Region (2020-2025)
- 4.2.2 Global Gene Therapy Revenue Forecast by Region (2026-2032)
- 5 Global Gene Therapy Market Size by Type and Application
- 5.1 Global Gene Therapy Market Size by Type (2020-2032)
- 5.2 Global Gene Therapy Market Size by Application (2020-2032)
- 6 North America
- 6.1 North America Gene Therapy Market Size and Growth Rate Analysis (2020-2032)
- 6.2 North America Key Manufacturers Analysis
- 6.3 North America Gene Therapy Market Size by Type
- 6.4 North America Gene Therapy Market Size by Application
- 6.5 North America Gene Therapy Market Size by Country
- 6.5.1 US
- 6.5.2 Canada
- 7 Europe
- 7.1 Europe Gene Therapy Market Size and Growth Rate Analysis (2020-2032)
- 7.2 Europe Key Manufacturers Analysis
- 7.3 Europe Gene Therapy Market Size by Type
- 7.4 Europe Gene Therapy Market Size by Application
- 7.5 Europe Gene Therapy Market Size by Country
- 7.5.1 Germany
- 7.5.2 France
- 7.5.3 United Kingdom
- 7.5.4 Italy
- 7.5.5 Spain
- 7.5.6 Benelux
- 8 China
- 8.1 China Gene Therapy Market Size and Growth Rate Analysis (2020-2032)
- 8.2 China Key Manufacturers Analysis
- 8.3 China Gene Therapy Market Size by Type
- 8.4 China Gene Therapy Market Size by Application
- 9 APAC (excl. China)
- 9.1 APAC (excl. China) Gene Therapy Market Size and Growth Rate Analysis (2020-2032)
- 9.2 APAC (excl. China) Key Manufacturers Analysis
- 9.3 APAC (excl. China) Gene Therapy Market Size by Type
- 9.4 APAC (excl. China) Gene Therapy Market Size by Application
- 9.5 APAC (excl. China) Gene Therapy Market Size by Country
- 9.5.1 Japan
- 9.5.2 South Korea
- 9.5.3 India
- 9.5.4 Australia
- 9.5.5 Southeast Asia
- 10 Latin America
- 10.1 Latin America Gene Therapy Market Size and Growth Rate Analysis (2020-2032)
- 10.2 Latin America Key Manufacturers Analysis
- 10.3 Latin America Gene Therapy Market Size by Type
- 10.4 Latin America Gene Therapy Market Size by Application
- 10.5 Latin America Gene Therapy Market Size by Country
- 10.5.1 Mexico
- 10.5.2 Brazil
- 11 Middle East & Africa
- 11.1 Middle East & Africa Gene Therapy Market Size and Growth Rate Analysis (2020-2032)
- 11.2 Middle East & Africa Key Manufacturers Analysis
- 11.3 Middle East & Africa Gene Therapy Market Size by Type
- 11.4 Middle East & Africa Gene Therapy Market Size by Application
- 11.5 Middle East & Africa Gene Therapy Market Size by Country
- 11.5.1 Saudi Arabia
- 11.5.2 South Africa
- 12 Competition by Manufacturers
- 12.1 Global Gene Therapy Market Revenue by Key Manufacturers (2021-2025)
- 12.2 Gene Therapy Competitive Landscape Analysis and Market Dynamic
- 12.2.1 Gene Therapy Competitive Landscape Analysis
- 12.2.2 Global Key Manufacturers Headquarter Location and Key Area Sales
- 12.2.3 Market Dynamic
- 13 Key Companies Analysis
- 13.1 Biogen
- 13.1.1 Biogen Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.1.2 Biogen Gene Therapy Product Portfolio
- 13.1.3 Biogen Gene Therapy Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 13.2 Novartis
- 13.2.1 Novartis Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.2.2 Novartis Gene Therapy Product Portfolio
- 13.2.3 Novartis Gene Therapy Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 13.3 Gilead Sciences
- 13.3.1 Gilead Sciences Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.3.2 Gilead Sciences Gene Therapy Product Portfolio
- 13.3.3 Gilead Sciences Gene Therapy Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 13.4 Sarepta Therapeutics
- 13.4.1 Sarepta Therapeutics Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.4.2 Sarepta Therapeutics Gene Therapy Product Portfolio
- 13.4.3 Sarepta Therapeutics Gene Therapy Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 13.5 Alnylam Pharmaceuticals
- 13.5.1 Alnylam Pharmaceuticals Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.5.2 Alnylam Pharmaceuticals Gene Therapy Product Portfolio
- 13.5.3 Alnylam Pharmaceuticals Gene Therapy Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 13.6 Amgen
- 13.6.1 Amgen Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.6.2 Amgen Gene Therapy Product Portfolio
- 13.6.3 Amgen Gene Therapy Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 13.7 Spark Therapeutics
- 13.7.1 Spark Therapeutics Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.7.2 Spark Therapeutics Gene Therapy Product Portfolio
- 13.7.3 Spark Therapeutics Gene Therapy Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 13.8 Akcea Therapeutics
- 13.8.1 Akcea Therapeutics Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.8.2 Akcea Therapeutics Gene Therapy Product Portfolio
- 13.8.3 Akcea Therapeutics Gene Therapy Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 13.9 bluebird bio
- 13.9.1 bluebird bio Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.9.2 bluebird bio Gene Therapy Product Portfolio
- 13.9.3 bluebird bio Gene Therapy Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 13.10 Sunway Biotech
- 13.10.1 Sunway Biotech Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.10.2 Sunway Biotech Gene Therapy Product Portfolio
- 13.10.3 Sunway Biotech Gene Therapy Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 13.11 AnGes
- 13.11.1 AnGes Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.11.2 AnGes Gene Therapy Product Portfolio
- 13.11.3 AnGes Gene Therapy Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 13.12 SIBIONO
- 13.12.1 SIBIONO Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.12.2 SIBIONO Gene Therapy Product Portfolio
- 13.12.3 SIBIONO Gene Therapy Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 13.13 Orchard Therapeutics
- 13.13.1 Orchard Therapeutics Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.13.2 Orchard Therapeutics Gene Therapy Product Portfolio
- 13.13.3 Orchard Therapeutics Gene Therapy Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 13.14 Human Stem Cells Institute
- 13.14.1 Human Stem Cells Institute Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.14.2 Human Stem Cells Institute Gene Therapy Product Portfolio
- 13.14.3 Human Stem Cells Institute Gene Therapy Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 14 Industry Chain Analysis
- 14.1 Gene Therapy Industry Chain Analysis
- 14.2 Gene Therapy Industry Raw Material and Suppliers Analysis
- 14.2.1 Gene Therapy Key Raw Material Supply Analysis
- 14.2.2 Raw Material Suppliers and Contact Information
- 14.3 Gene Therapy Typical Downstream Customers
- 14.4 Gene Therapy Sales Channel Analysis
- 15 Research Findings and Conclusion
- 16 Methodology and Data Source
- 16.1 Methodology/Research Approach
- 16.2 Research Scope
- 16.3 Benchmarks and Assumptions
- 16.4 Date Source
- 16.4.1 Primary Sources
- 16.4.2 Secondary Sources
- 16.5 Data Cross Validation
- 16.6 Disclaimer
Research Assistance
Download our eBook: How to Succeed Using Market Research
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook